Rolf Lewensohn

发表

Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.

Chuen Seng Tan, Jenny Forshed, Yudi Pawitan, 2008, Journal of proteome research.

Robustness and accuracy of high speed LC-MS separations for global peptide quantitation and biomarker discovery.

Yang Yang, Johan Lengqvist, Janne Lehtiö, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.

Jan Nyman, Karl-Axel Johansson, Lars Ekberg, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

Jan Nyman, Lars Ekberg, Christer Sederholm, 2011, Acta oncologica.

Modulation of response to radiation of human lung cancer cells following insulin-like growth factor 1 receptor inactivation.

Lena Kanter, Rolf Lewensohn, J. Castro, 2005, Cancer letters.

Creating a data exchange strategy for radiotherapy research: Towards federated databases and anonymised public datasets

Andre Dekker, Uwe Just, Mechthild Krause, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair.

Ulf Hellman, David J. Chen, Rolf Lewensohn, 2011, Genes & development.

Annotated regions of significance of SELDI‐TOF‐MS spectra for detecting protein biomarkers

Andreas Quandt, Yudi Pawitan, Janne Lehtiö, 2006, Proteomics.

SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.

Jan Nyman, Bengt Bergman, Erik Holmberg, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities

Joakim Lundeberg, Henrik Gréen, Andrea Lindgren, 2015, Clinical Cancer Research.

Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.

Boris Zhivotovsky, Janne Lehtiö, Rolf Lewensohn, 2011, Journal of proteome research.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Jan Nyman, Karl-Axel Johansson, Lars Ekberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries

Jan Nyman, Karl-Axel Johansson, Lars Ekberg, 2006, Acta oncologica.

Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.

Boris Zhivotovsky, Rolf Lewensohn, B. Joseph, 2002, Experimental cell research.

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.

Lukas M Orre, Janne Lehtiö, Maria Pernemalm, 2009, Lung cancer.

The role of p53 in treatment responses of lung cancer.

Rolf Lewensohn, R. Lewensohn, K. Viktorsson, 2005, Biochemical and biophysical research communications.